Journals / Türk Patoloji Dergisi / 2020 / Cilt: 36 - Sayı: 3

Diagnostic Utility of Immunohistochemical Expressions of IMP3 Versus DOG1 and p63 in Salivary Gland Tumors

Pages
227–236
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A statistically significant relationship was noticed between salivarygland tumors and p63 immunostaining (P

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The diverse site of origin and classification complexity of salivary glands tumors increase difficulties in their diagnosis.
📊
Key Findings & Data:This studyaimed to evaluate the specificity and diagnostic ability of immunohistochemical expressions of IMP3 versus DOG1 and p63 in cases of suchtumors.Material and Method: Thirty paraffin-embedded salivary gland tumors were obtained from the Pathology Department Archive.
💡
Conclusion & Impact:A statistically significant relationship was noticed between salivarygland tumors and p63 immunostaining (P
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The diverse site of origin and classification complexity of salivary glands tumors increase difficulties in their diagnosis. This studyaimed to evaluate the specificity and diagnostic ability of immunohistochemical expressions of IMP3 versus DOG1 and p63 in cases of suchtumors.Material and Method: Thirty paraffin-embedded salivary gland tumors were obtained from the Pathology Department Archive. Their diagnosiswas confirmed. The specimens were then re-classified and evaluated using the IMP3, DOG1 and p63 immunohistochemical markers.Results: There were 8 pleomorphic adenoma (PA), 12 mucoepidermoid carcinoma (MEC) and 10 adenoid cystic carcinoma (ADC) cases. All12 MECs (100%) were IMP3 positive, while 30% of ADCs and only 25% of PAs were positive for IMP3. There was a statistically significantrelationship between salivary gland tumors and IMP3 immunostaining (P =0.03). As regards to DOG1 results, 12.5% of PAs showed variableluminal positive immunostaining and 40% of ADCs showed weak luminal and abluminal immunostaining while 16.7% of MEC showedcytoplasmic staining. On the other hand, all ADCs (100%) showed moderate p63 reactivity in the nuclei of abluminal cells. All MEC cases(100%) were also p63-positive, showing a strong diffuse nuclear reactivity. A statistically significant relationship was noticed between salivarygland tumors and p63 immunostaining (P

🔖

Cite This Article

IBRAHIM, T. R., AHMED, M. M., HEGAZY, A. A. (2022). Diagnostic Utility of Immunohistochemical Expressions of IMP3 Versus DOG1 and p63 in Salivary Gland Tumors. Türk Patoloji Dergisi, Cilt: 36 - Sayı: 3, 227–236. https://ajindex.com/articles/640414

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Nagao T, Sato E, Inoue R, Oshiro H, Reisuke H. Takahashi, Nagai T, Yoshida M, Suzuki F, Obikane H, Yamashina M, Matsubayashi J. Immunohistochemical analysis of salivary gland tumors: Application for surgical pathology practice. Acta Histochem Cytochem. 2012;45:269-82
  2. Cheuk W, Chan JK. Advances in salivary gland pathology. Histopathol. 2007;51:1-20
  3. Speight PM, Barrett AW. Prognostic factors in malignant tumours of the salivary glands. Br J Oral Maxillofac Surg. 2009;47:587-93
  4. Eveson JW, Auclair P, Gnepp DR, El-Naggar AK. Tumours of the salivary glands. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005. 9:168
  5. Elshafey MR, Ahmed RA, Mourad M, Gaballah ET. The oncofetal protein IMP3 is an indicator of early recurrence and poor outcome in mucoepidermoid carcinoma of salivary glands. Cancer Biol Med. 2016;13:289-95
  6. Yang C, Zhang L, Sanati S. SOX10 is a sensitive marker for breast and salivary gland adenoid cystic carcinoma: Immunohistochemical characterization of adenoid cystic carcinomas. Breast Cancer (Auckl). 2019;13:1-6
  7. Rotellini, M, Palomba A, Baroni G, Franchi A. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors. Appl Immunohistochem Mol Morphol. 2014;22:390-4
  8. Isomerism AB, Ferreira SV, Lessa AM, Pereira Junior AS, Gurgel CA, Coutinho-Camilo CM, Soares FA, Vilas-Boas DS, Vidal MT, Santos JN. Insulin-like growth factor II messenger RNA-binding protein 3 in salivary gland tumors. Appl Immunohistochem Mol Morphol. 2016;24:422-6
  9. Burdelski C, Jakani-Karimi N, Jacobsen F, Möller-Koop C, Minner S, Simon R, Sauter G, Steurer S, Clauditz T, Wilczak W. IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues. Oncology Reports. 2018;39:3-12
  10. Abd Rabbah NM, Hakim SA. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas. Int J Clin Exp Pathol. 2015;8:9214-22
  11. Atta IS, Al Qahtani FN. DOG1, alpha-amylase and p63 expression in acinic cell carcinoma of salivary gland; immunohistochemical, clinical and radiological study. J Histol Histopathol. 2015;2:13
  12. Schaeffer DF, Owen DR, Lim HJ, Buczkowski AK, Chung SW, Scudamore CH, Huntsman DG, Ng SSW and Owen DA. Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) o